Author name: EuMe-adm

telehealth and ISO 13131

Navigating ISO 13131: challenges for MedTech manufacturers?

ISO standard 13131 provides a framework for managing telehealth services as part of the medical device environment. It combines the baselines of standards for risk management and medical devices with regulatory requirements derived from the AI (Artificial Intelligence) Act, Data Act and GDPR. Laws/ regulations / guidelines: ISO 13131:2021 ISO 13485:2016 ISO 14971:2019 ISO 31000:2018 […]

Navigating ISO 13131: challenges for MedTech manufacturers? Read More »

Update – MDCG 2022-9 rev.1 – Summary of safety and performance template

Yesterday, revision 1 of the MDCG guidance 2022-9 was published. It provides clarification regarding Summary of Safety and Performance template, especially when devices are intended to be used by lay persons only. Please make sure, that you clearly distinct the user groups in your intended purpose definition and also keep in mind: The Summary of

Update – MDCG 2022-9 rev.1 – Summary of safety and performance template Read More »

MDR: New Bundestag discussion on impact on MedTech supply

BVMed news: On 11th April 2024, the Bundestag will discuss the impact of the EU Medical Devices Regulation (MDR) on medical device supply. This follows a motion by the Union faction, postponed from January, which calls for: – Complementing the current regulatory system – Increasing the efficiency of the system – Reform of the five-year

MDR: New Bundestag discussion on impact on MedTech supply Read More »

EU2023/2713 EU reference laboratories for IVD medical devices

Designation of EU Reference Laboratories: The regulation, dated December 6, 2023, designates specific laboratories in the European Union as EU reference laboratories for in vitro diagnostic medical devices. This designation is in accordance with Regulation (EU) 2017/746 and involves a thorough selection process based on criteria outlined in the regulation. Annual Review Process: The Commission

EU2023/2713 EU reference laboratories for IVD medical devices Read More »

MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature

Annual Revision Process: The European Medical Device Nomenclature (EMDN) undergoes an annual review and update process, involving four distinct phases: Collection of requests, Evaluation and analysis, Validation and endorsement, and MDCG endorsement and publication. Actors Involved: The key actors in managing and maintaining the EMDN include the Nomenclature working group (NOM WG), European Medical Device

MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature Read More »

Final rule regarding amendment of 21 CFR Part 820 & 21 CFR Part 4

The Food and Drug Administration (FDA) is issuing a final rule to amend the device current good manufacturing practice (CGMP) requirements of the Quality System (QS) regulation to harmonize and modernize the regulation. The new regulation will incoporating reference to ISO 13485 medical device management system standard (edition 2016) and allows manufacturers to profit not

Final rule regarding amendment of 21 CFR Part 820 & 21 CFR Part 4 Read More »